Tag: Peter Marks

FDA Vaccine Chief Suggests Its Time to Move on From mRNA COVID Vaccines

October 25, 2022
AMERICACCP VirusCOVID-19FDAPeter MarksUSUS NewsVaccines & Safety
0 Comment

The head of the Food and Drug Administration’s (FDA) vaccine division suggested that it may be time to move on from using mRNA COVID-19 vaccines. The two most commonly used vaccines—made by Pfizer and Moderna—use mRNA technology. Johnson & Johnson’s vaccine uses an adenovirus and Novavax’s shot, the most recently approved vaccine for COVID-19 in…

Read More

FDA Official Defends Bypassing Expert Panel When Clearing Fourth COVID-19 Shots

April 6, 2022
AMERICABrightCCP VirusCovid NewshealthHealth NewsPeter MarksPolicies & ImpactsUSVaccineVaccines & Safety
0 Comment

A Food and Drug Administration (FDA) official on April 6 defended the agency’s recent decision to authorize fourth COVID-19 vaccine doses for millions of Americans without convening its expert advisory panel. Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation and Research, downplayed the authorization, claiming it was not “a major expansion or a…

Read More

Fifth COVID-19 Vaccine Shot May Be Needed in Fall: FDA Official

March 29, 2022
BrightCCP VirusCovid NewsEditor's PicksFDAhealthHealth NewsPeter MarksVaccines & Safety
0 Comment

Hours after the Food and Drug Administration (FDA) authorized a fourth shot of the Moderna and Pfizer COVID-19 vaccines for all Americans 50 and older, an FDA official said a fifth shot may be needed in the fall. “I don’t want to shock anyone but there may be a need for people to get an…

Read More